查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1762088

生物相似药市场分析及预测（至 2034 年）：类型、产品、应用、最终用户、技术、流程、组件、阶段、服务、设备

Biosimilars Market Analysis and Forecast to 2034: Type, Product, Application, End User, Technology, Process, Component, Stage, Services, Device
出版日期: | 出版商: Global Insight Services | 英文 390 Pages | 商品交期: 3-5个工作天内

价格
简介目录

生物相似药市场规模预计将从2024年的240亿美元增加至2034年的1,177亿美元，复合年增长率约为17.3%。生物相似生物製药市场涵盖与已核准的参考製剂高度相似，但在安全性和有效性方面无临床意义差异的生物药物。生技药品专利到期推动了市场发展，这增加了对经济高效且价格合理的医疗保健解决方案的需求。各地区的法规结构正在不断发展，以支持生物相似药的核准，鼓励创新和竞争。随着医疗保健系统寻求在成本压力和对先进治疗方案的需求之间取得平衡，生物相似药市场预计将大幅成长。

行业概览

生物相似药市场正面临全球关税、地缘政治紧张局势和不断变化的供应链动态等复杂局面。日本和韩国正在策略性地加强其生物相似药能力，利用创新来减轻关税的影响并减少对外国生技药品的依赖。中国正在国家支持下培育强大的国内生物相似药产业，并越来越注重自力更生。台湾虽然在生物製药製造业中举足轻重，但在美国摩擦中面临地缘政治脆弱性。在全球范围内，由于生技药品具有成本效益的替代品和人口老化，生物相似药市场蓬勃发展。在弹性供应链和策略联盟的推动下，预计到 2035 年市场将大幅扩张。中东衝突主要影响能源价格，但间接影响生物相似药的生产成本和全球分销物流。

市场区隔
类型 重组糖基化蛋白、重组非糖基化蛋白、多胜肽
产品 单株抗体、胰岛素、红血球生成素、颗粒细胞增生因子、人体生长荷尔蒙、干扰素、不孕激素
目的 癌症、慢性病、自体免疫疾病、血液疾病、感染疾病、生长激素缺乏症
最终用户 医院、诊所、研究机构、製药和生物技术公司
科技 重组DNA技术、单株抗体技术、蛋白质序列测定、生物资讯学
流程 上游工程、下游工序
成分 原料药，最终製剂
步 临床试验、临床前试验和商业化
服务 契约製造、合约研究、医药咨询
装置 生物反应器、层析法系统

市场概况：

生物相似药市场持续强劲扩张，主要原因是对具有成本效益的生物製药的需求不断增长以及原厂生技药品专利到期。肿瘤学领域则受到癌症发生率上升和参考生技药品高成本的驱动。肿瘤学生物仿製药对医疗保健提供者和付款人极具吸引力，因为它们可以显着节省成本并具有相当的疗效。此外，生物製药开发和製造技术的进步正在推动生物相似药的应用。自体免疫疾病和糖尿病等新兴细分市场预计将出现显着增长，这归因于这些疾病的发病率上升以及医生和患者对生物相似药的接受度不断提高。自体免疫疾病领域尤其有望受益于单株抗体的技术创新和下一代生物相似药的开发，这些创新有望改善患者的治疗效果并扩大治疗选择，从而显着影响市场动态。

竞争概况：

生物相似药市场以市场占有率分布的动态变化为特征。由于癌症发病率的上升以及对经济高效的替代疗法的需求，肿瘤学领域成为当之无愧的领导者。由于自体免疫疾病的发病率上升以及对经济实惠的替代疗法的需求，免疫学领域紧随其后。按地区划分，欧洲凭藉完善的法律规范和高渗透率保持市场主导地位；而亚太地区则在医疗支出增长和政府扶持措施的推动下，正经历强劲增长。为了在这个快速成长的市场中占据更大份额，产业主要企业正透过策略联盟和产品发布积极强化其产品组合。生物相似药市场的竞争格局在很大程度上受到监管因素的影响，尤其是在欧洲和北美等地区，这些地区严格的核准流程确保了产品的安全性和有效性。安进、山德士和辉瑞等公司处于领先地位，利用其强大的研发能力和策略联盟来获得竞争优势。展望未来，随着数款重磅生技药品专利到期，以及生物相似药日益受到医疗专业人士和患者的认可，生物相似药市场预计将大幅成长。然而，智慧财产权纠纷和市场准入壁垒等挑战依然存在。不过，生物技术的进步和持续的监管支持预计将为市场扩张带来机会。

主要趋势和驱动因素：

随着重磅生技药品专利到期，生物相似药市场迎来了强劲成长，竞争更加激烈。慢性病的盛行需要经济有效的治疗方案，这进一步推动了这个趋势。各国政府和医疗机构正积极推广生物相似药的应用，以降低医疗成本。生物相似药开发和生产领域的技术进步正在提高产品品质并缩短上市时间。这项进步对于获得监管部门的核准和促进市场认可至关重要。此外，大型製药公司不断增加的研发投入正在刺激创新，从而催生出强大的生物相似药产品线。製药公司之间的合作与伙伴关係也在不断增多，旨在利用专业知识并共用资源。这些趋势正在加速生物相似药的开发和商业化，扩大市场基础。此外，医疗专业人员和患者对生物相似药的认知度和接受度不断提高也在推动市场需求。随着生物相似药变得越来越普遍，医疗保健基础设施快速发展的新兴市场充满了成长机会，为产业参与者提供了巨大的成长潜力。

限制与挑战：

生物相似药市场面临几大限制和挑战。主要挑战是监管的复杂性和地区差异，这会导致核准延迟并增加成本。这种复杂性通常需要进行大量的临床试验，这增加了製造商的财务负担。此外，医生对开立生物相似药的认知度和信任度严重不足，阻碍了其采用。包括专利诉讼在内的智慧财产权纠纷也是市场进入和扩张的障碍。此外，需要建立强大的药物安全检测系统来监测生物相似药上市后的安全性和有效性，也带来了物流和财务挑战。最后，儘管生物相似药具有成本优势，但人们对原厂生物製剂的品牌忠诚度根深蒂固，使得其难以扩大市场占有率。总之，这些因素阻碍了生物相似药在医疗保健市场的快速成长和广泛接受。

目录

第一章生物相似药市场概述

  • 研究目标
  • 生物相似药市场定义和范围
  • 报告限制
  • 调查年份和货币
  • 调查方法

第二章执行摘要

第三章重要考察

第四章生物相似药市场展望

  • 生物相似药市场细分
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章：生物相似药市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买意向
  • 案例研究分析
  • 定价分析
  • 监管状况
  • 供应链分析
  • 竞争产品分析
  • 近期动态

第六章：生物相似药市场规模

  • 生物相似药市场规模（以价值计算）
  • 生物相似药市场规模（按数量计算）

第七章 生物相似药市场（按类型）

  • 市场概览
  • 重组糖基化蛋白
  • 重组非糖基化蛋白
  • 胜肽
  • 其他的

第 8 章 生物相似药市场（按产品）

  • 市场概览
  • 单株抗体
  • 胰岛素
  • 促红血球生成素
  • 颗粒细胞增生因子
  • 人体生长荷尔蒙
  • 干扰素
  • 生育激素
  • 其他的

第九章生物相似药市场（按应用）

  • 市场概览
  • 肿瘤学
  • 慢性病
  • 自体免疫疾病
  • 血液系统疾病
  • 感染疾病
  • 生长激素缺乏症
  • 其他的

第 10 章 生物相似药市场（按最终用户）

  • 市场概览
  • 医院
  • 诊所
  • 研究所
  • 製药公司
  • 生技公司
  • 其他的

第 11 章 生物相似药市场（按技术）

  • 市场概览
  • 重组DNA技术
  • 单株抗体技术
  • 蛋白质序列测定
  • 生物资讯学
  • 其他的

第 12 章 生物相似药市场（按製程）

  • 市场概览
  • 上游工程
  • 下游工序
  • 其他的

第 13 章。生物相似药市场（按成分）

  • 市场概览
  • 原料药(API)
  • 成品配方
  • 其他的

第 14 章生物相似药市场分阶段

  • 市场概览
  • 临床试验
  • 临床前试验
  • 商业化
  • 其他的

第十五章 生物相似药市场（依服务）

  • 市场概览
  • 契约製造
  • 委託研究
  • 监理咨询
  • 其他的

第十六章 生物相似药市场（按设备）

  • 市场概览
  • 生物反应器
  • 层析法系统
  • 其他的

第十七章 生物相似药市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十八章竞争格局

  • 概述
  • 市场占有率分析
  • 主要企业定位
  • 衝突领导地图
  • 供应商基准化分析
  • 发展策略基准化分析

第十九章 公司简介

  • Alvotech
  • Coherus BioSciences
  • Amgen
  • Samsung Bioepis
  • Celltrion
  • Biocon
  • Sandoz
  • Mylan
  • Fresenius Kabi
  • Stada Arzneimittel
  • Dr Reddy's Laboratories
  • Lupin
  • Hikma Pharmaceuticals
  • Apotex
  • Teva Pharmaceutical Industries
  • Zydus Cadila
  • Torrent Pharmaceuticals
  • Cadila Healthcare
  • Alkem Laboratories
  • Gedeon Richter
简介目录
Product Code: GIS20363

Biosimilars Market is anticipated to expand from $24.0 billion in 2024 to $117.7 billion by 2034, growing at a CAGR of approximately 17.3%. Biosimilars Market encompasses biologic medical products highly similar to already approved reference products, offering no clinically meaningful differences in safety or efficacy. This market is driven by patent expirations of biologics, cost-effectiveness, and increasing demand for affordable healthcare solutions. Regulatory frameworks in various regions are evolving to support biosimilar approvals, fostering innovation and competition. The market is poised for significant growth as healthcare systems seek to balance cost pressures with the need for advanced therapeutic options.

Industry Overview:

The biosimilars market is navigating a complex landscape of global tariffs, geopolitical tensions, and evolving supply chain dynamics. Japan and South Korea are strategically enhancing their biosimilar capabilities, leveraging innovation to mitigate tariff impacts and reduce dependency on foreign biologics. China's focus on self-reliance is intensifying, with state-backed initiatives fostering a robust domestic biosimilars sector. Taiwan, while pivotal in biopharmaceutical manufacturing, faces geopolitical vulnerabilities amidst US-China frictions. Globally, the biosimilars market is buoyant, driven by cost-effective alternatives to biologics and an aging population. By 2035, the market is poised for significant expansion, contingent on resilient supply chains and strategic alliances. Middle East conflicts, while primarily affecting energy prices, indirectly influence biosimilar production costs and distribution logistics worldwide.

Market Segmentation
TypeRecombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Peptides
ProductMonoclonal Antibodies, Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor, Human Growth Hormone, Interferons, Fertility Hormones
ApplicationOncology, Chronic Diseases, Autoimmune Diseases, Blood Disorders, Infectious Diseases, Growth Hormone Deficiency
End UserHospitals, Clinics, Research Institutes, Pharmaceutical Companies, Biotechnology Firms
TechnologyRecombinant DNA Technology, Monoclonal Antibody Technology, Protein Sequencing, Bioinformatics
ProcessUpstream Processing, Downstream Processing
ComponentActive Pharmaceutical Ingredients (API), Finished Dosage Formulations
StageClinical Trials, Preclinical Studies, Commercialization
ServicesContract Manufacturing, Contract Research, Regulatory Consulting
DeviceBioreactors, Chromatography Systems

Market Overview:

The Biosimilars Market is experiencing robust expansion, primarily fueled by the rising need for cost-effective biologic therapies and the expiration of patents for original biologics. The oncology segment leads the market, driven by the increasing prevalence of cancer and the high cost of reference biologics. Biosimilars in oncology offer significant cost savings and comparable efficacy, making them highly attractive to healthcare providers and payers. Furthermore, advancements in biologic drug development and manufacturing technologies enhance their adoption. Emerging sub-segments, such as autoimmune diseases and diabetes, are poised for substantial growth due to the rising incidence of these conditions and the growing acceptance of biosimilars among physicians and patients. The autoimmune segment, in particular, is expected to benefit from ongoing innovations in monoclonal antibodies and the development of next-generation biosimilars, which promise improved patient outcomes and expanded therapeutic options, thereby significantly impacting market dynamics.

Geographical Overview:

The biosimilars market is witnessing remarkable growth, with regional dynamics playing a pivotal role. In North America, the market is expanding due to a robust regulatory framework and increasing healthcare expenditure. The United States, a key player, is driving growth through strategic collaborations and a focus on reducing healthcare costs. Europe stands as a leader in the biosimilars market, propelled by supportive government policies and a strong emphasis on cost-effective healthcare solutions. The region's well-established pharmaceutical industry and high acceptance rates among healthcare professionals further contribute to its dominance. Germany and the United Kingdom are at the forefront. In Asia Pacific, the biosimilars market is experiencing rapid expansion. This growth is driven by a surge in chronic diseases and an aging population. Countries like China and India are investing heavily in biosimilar development and manufacturing. Their large patient pools and increasing healthcare access further bolster market potential. Latin America is an emerging market for biosimilars, with growing awareness and acceptance among healthcare providers. Brazil and Mexico are leading the way, focusing on regulatory improvements and cost-saving initiatives. The region's potential is significant, given its evolving healthcare landscape. The Middle East & Africa region is gradually recognizing the benefits of biosimilars. The market here is driven by the need to improve healthcare affordability and accessibility. Countries like Saudi Arabia and South Africa are making strides in adopting biosimilars to enhance healthcare outcomes and economic efficiency.

Competition Overview:

The biosimilars market is characterized by a dynamic distribution of market share, with the oncology segment emerging as a prominent leader due to the increasing prevalence of cancer and the demand for cost-effective treatment alternatives. The immunology segment follows closely, driven by the rising incidence of autoimmune diseases and the subsequent need for affordable therapeutic options. Geographically, Europe maintains a leadership position in the market due to its well-established regulatory framework and high adoption rates, while the Asia-Pacific region is witnessing robust growth fueled by increasing healthcare expenditure and supportive government initiatives. Key industry players are actively enhancing their portfolios through strategic collaborations and product launches to capture a larger share of this burgeoning market. The competitive landscape of the biosimilars market is shaped significantly by regulatory influences, particularly in regions like Europe and North America, where stringent approval processes ensure product safety and efficacy. Companies such as Amgen, Sandoz, and Pfizer are at the forefront, leveraging their extensive research capabilities and strategic alliances to gain competitive advantage. Looking ahead, the market is poised for substantial growth, driven by the expiration of patents for several blockbuster biologics and the increasing acceptance of biosimilars among healthcare providers and patients. However, challenges such as intellectual property disputes and market entry barriers persist. Nonetheless, advancements in biotechnology and ongoing regulatory support are expected to create lucrative opportunities for market expansion.

Recent Developments:

The biosimilars market has experienced notable developments in recent months. Amgen announced a strategic partnership with a leading European pharmaceutical company to co-develop and commercialize a new biosimilar targeting autoimmune diseases, aiming to expand their presence in the European market. In regulatory news, the U.S. FDA approved a groundbreaking biosimilar for treating cancer, marking a significant milestone in oncology therapeutics and potentially reducing treatment costs. Pfizer and Biocon Biologics entered a joint venture to enhance their biosimilars portfolio, focusing on emerging markets in Asia and Africa, which are projected to see substantial growth in demand. Market analysts reported a surge in biosimilars adoption in the European Union, driven by favorable regulatory policies and increased physician acceptance, which is expected to boost market growth. Lastly, a prominent South Korean biosimilar manufacturer announced a major investment to expand its production facilities, aiming to meet the growing global demand for cost-effective biologic treatments. These developments underscore the dynamic nature of the biosimilars market, highlighting opportunities for growth and innovation.

Key Companies:

Alvotech, Coherus Bio Sciences, Amgen, Samsung Bioepis, Celltrion, Biocon, Sandoz, Mylan, Fresenius Kabi, Stada Arzneimittel, Dr Reddy's Laboratories, Lupin, Hikma Pharmaceuticals, Apotex, Teva Pharmaceutical Industries, Zydus Cadila, Torrent Pharmaceuticals, Cadila Healthcare, Alkem Laboratories, Gedeon Richter

Key Trends and Drivers:

The biosimilars market is experiencing robust growth, propelled by the expiration of patents for blockbuster biologics, which opens the market to biosimilar competition. This trend is further driven by the increasing prevalence of chronic diseases, which necessitates cost-effective treatment options. Governments and healthcare providers are actively promoting the adoption of biosimilars to reduce healthcare expenditure. Technological advancements in the development and manufacturing of biosimilars are enhancing product quality and reducing time-to-market. This progress is crucial in gaining regulatory approval and fostering market acceptance. Additionally, the growing investment in research and development by key pharmaceutical companies is fueling innovation, leading to a broader pipeline of biosimilar products. The market is also witnessing increased collaborations and partnerships among pharmaceutical companies to leverage expertise and share resources. This trend is accelerating the development and commercialization of biosimilars, thus expanding market reach. Moreover, the rising awareness and acceptance of biosimilars among healthcare professionals and patients are driving market demand. As biosimilars continue to gain traction, opportunities abound in emerging markets where healthcare infrastructure is rapidly evolving, presenting significant growth potential for industry players.

Restraints and Challenges:

The biosimilars market encounters several significant restraints and challenges. A primary challenge is the regulatory complexity and variability across regions, which can delay approvals and increase costs. This complexity often necessitates extensive clinical trials, adding to the financial burden on manufacturers. Furthermore, there is a notable lack of physician awareness and confidence in prescribing biosimilars, which hampers their adoption. Intellectual property disputes, including patent litigations, can also obstruct market entry and expansion. Additionally, the need for robust pharmacovigilance systems to monitor biosimilar safety and efficacy post-launch poses logistical and financial challenges. Lastly, the entrenched brand loyalty to original biologics makes it difficult for biosimilars to gain market share, despite their cost advantages. These factors collectively impede the swift growth and broader acceptance of biosimilars in the healthcare market.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Biosimilars Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Biosimilars Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Application
  • 2.6 Key Highlights of the Market, by End User
  • 2.7 Key Highlights of the Market, by Technology
  • 2.8 Key Highlights of the Market, by Process
  • 2.9 Key Highlights of the Market, by Component
  • 2.10 Key Highlights of the Market, by Stage
  • 2.11 Key Highlights of the Market, by Services
  • 2.12 Key Highlights of the Market, by Device
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Application
  • 3.5 Market Attractiveness Analysis, by End User
  • 3.6 Market Attractiveness Analysis, by Technology
  • 3.7 Market Attractiveness Analysis, by Process
  • 3.8 Market Attractiveness Analysis, by Component
  • 3.9 Market Attractiveness Analysis, by Stage
  • 3.10 Market Attractiveness Analysis, by Services
  • 3.11 Market Attractiveness Analysis, by Device
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Biosimilars Market Outlook

  • 4.1 Biosimilars Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Biosimilars Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Biosimilars Market Size

  • 6.1 Biosimilars Market Size, by Value
  • 6.2 Biosimilars Market Size, by Volume

7: Biosimilars Market, by Type

  • 7.1 Market Overview
  • 7.2 Recombinant Glycosylated Proteins
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Recombinant Non-Glycosylated Proteins
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Peptides
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: Biosimilars Market, by Product

  • 8.1 Market Overview
  • 8.2 Monoclonal Antibodies
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Insulin
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Erythropoietin
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Granulocyte Colony-Stimulating Factor
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Human Growth Hormone
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Interferons
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Fertility Hormones
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Others
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region

9: Biosimilars Market, by Application

  • 9.1 Market Overview
  • 9.2 Oncology
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Chronic Diseases
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Autoimmune Diseases
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Blood Disorders
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Infectious Diseases
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Growth Hormone Deficiency
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Others
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region

10: Biosimilars Market, by End User

  • 10.1 Market Overview
  • 10.2 Hospitals
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Clinics
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Research Institutes
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Pharmaceutical Companies
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Biotechnology Firms
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Biosimilars Market, by Technology

  • 11.1 Market Overview
  • 11.2 Recombinant DNA Technology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Monoclonal Antibody Technology
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Protein Sequencing
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Bioinformatics
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Biosimilars Market, by Process

  • 12.1 Market Overview
  • 12.2 Upstream Processing
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Downstream Processing
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Others
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region

13: Biosimilars Market, by Component

  • 13.1 Market Overview
  • 13.2 Active Pharmaceutical Ingredients (API)
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Finished Dosage Formulations
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Biosimilars Market, by Stage

  • 14.1 Market Overview
  • 14.2 Clinical Trials
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Preclinical Studies
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Commercialization
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Biosimilars Market, by Services

  • 15.1 Market Overview
  • 15.2 Contract Manufacturing
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Contract Research
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Regulatory Consulting
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Biosimilars Market, by Device

  • 16.1 Market Overview
  • 16.2 Bioreactors
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Chromatography Systems
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Others
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region

17: Biosimilars Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Application
    • 17.2.5 North America Market Size and Forecast, by End User
    • 17.2.6 North America Market Size and Forecast, by Technology
    • 17.2.7 North America Market Size and Forecast, by Process
    • 17.2.8 North America Market Size and Forecast, by Component
    • 17.2.9 North America Market Size and Forecast, by Stage
    • 17.2.10 North America Market Size and Forecast, by Services
    • 17.2.11 North America Market Size and Forecast, by Device
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Application
      • 17.2.9.4 United States Market Size and Forecast, by End User
      • 17.2.9.5 United States Market Size and Forecast, by Technology
      • 17.2.9.6 United States Market Size and Forecast, by Process
      • 17.2.9.7 United States Market Size and Forecast, by Component
      • 17.2.9.8 United States Market Size and Forecast, by Stage
      • 17.2.9.9 United States Market Size and Forecast, by Services
      • 17.2.9.10 United States Market Size and Forecast, by Device
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Application
      • 17.2.10.4 Canada Market Size and Forecast, by End User
      • 17.2.10.5 Canada Market Size and Forecast, by Technology
      • 17.2.10.6 Canada Market Size and Forecast, by Process
      • 17.2.10.7 Canada Market Size and Forecast, by Component
      • 17.2.10.8 Canada Market Size and Forecast, by Stage
      • 17.2.10.9 Canada Market Size and Forecast, by Services
      • 17.2.10.10 Canada Market Size and Forecast, by Device
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Application
    • 17.3.5 Europe Market Size and Forecast, by End User
    • 17.3.6 Europe Market Size and Forecast, by Technology
    • 17.3.7 Europe Market Size and Forecast, by Process
    • 17.3.8 Europe Market Size and Forecast, by Component
    • 17.3.9 Europe Market Size and Forecast, by Stage
    • 17.3.10 Europe Market Size and Forecast, by Services
    • 17.3.11 Europe Market Size and Forecast, by Device
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.4 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Component
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Device
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Application
      • 17.3.10.4 Germany Market Size and Forecast, by End User
      • 17.3.10.5 Germany Market Size and Forecast, by Technology
      • 17.3.10.6 Germany Market Size and Forecast, by Process
      • 17.3.10.7 Germany Market Size and Forecast, by Component
      • 17.3.10.8 Germany Market Size and Forecast, by Stage
      • 17.3.10.9 Germany Market Size and Forecast, by Services
      • 17.3.10.10 Germany Market Size and Forecast, by Device
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Application
      • 17.3.11.4 France Market Size and Forecast, by End User
      • 17.3.11.5 France Market Size and Forecast, by Technology
      • 17.3.11.6 France Market Size and Forecast, by Process
      • 17.3.11.7 France Market Size and Forecast, by Component
      • 17.3.11.8 France Market Size and Forecast, by Stage
      • 17.3.11.9 France Market Size and Forecast, by Services
      • 17.3.11.10 France Market Size and Forecast, by Device
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Application
      • 17.3.12.4 Spain Market Size and Forecast, by End User
      • 17.3.12.5 Spain Market Size and Forecast, by Technology
      • 17.3.12.6 Spain Market Size and Forecast, by Process
      • 17.3.12.7 Spain Market Size and Forecast, by Component
      • 17.3.12.8 Spain Market Size and Forecast, by Stage
      • 17.3.12.9 Spain Market Size and Forecast, by Services
      • 17.3.12.10 Spain Market Size and Forecast, by Device
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Application
      • 17.3.13.4 Italy Market Size and Forecast, by End User
      • 17.3.13.5 Italy Market Size and Forecast, by Technology
      • 17.3.13.6 Italy Market Size and Forecast, by Process
      • 17.3.13.7 Italy Market Size and Forecast, by Component
      • 17.3.13.8 Italy Market Size and Forecast, by Stage
      • 17.3.13.9 Italy Market Size and Forecast, by Services
      • 17.3.13.10 Italy Market Size and Forecast, by Device
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Application
      • 17.3.14.4 Netherlands Market Size and Forecast, by End User
      • 17.3.14.5 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.6 Netherlands Market Size and Forecast, by Process
      • 17.3.14.7 Netherlands Market Size and Forecast, by Component
      • 17.3.14.8 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.9 Netherlands Market Size and Forecast, by Services
      • 17.3.14.10 Netherlands Market Size and Forecast, by Device
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Application
      • 17.3.15.4 Sweden Market Size and Forecast, by End User
      • 17.3.15.5 Sweden Market Size and Forecast, by Technology
      • 17.3.15.6 Sweden Market Size and Forecast, by Process
      • 17.3.15.7 Sweden Market Size and Forecast, by Component
      • 17.3.15.8 Sweden Market Size and Forecast, by Stage
      • 17.3.15.9 Sweden Market Size and Forecast, by Services
      • 17.3.15.10 Sweden Market Size and Forecast, by Device
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Application
      • 17.3.16.4 Switzerland Market Size and Forecast, by End User
      • 17.3.16.5 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.6 Switzerland Market Size and Forecast, by Process
      • 17.3.16.7 Switzerland Market Size and Forecast, by Component
      • 17.3.16.8 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.9 Switzerland Market Size and Forecast, by Services
      • 17.3.16.10 Switzerland Market Size and Forecast, by Device
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Application
      • 17.3.17.4 Denmark Market Size and Forecast, by End User
      • 17.3.17.5 Denmark Market Size and Forecast, by Technology
      • 17.3.17.6 Denmark Market Size and Forecast, by Process
      • 17.3.17.7 Denmark Market Size and Forecast, by Component
      • 17.3.17.8 Denmark Market Size and Forecast, by Stage
      • 17.3.17.9 Denmark Market Size and Forecast, by Services
      • 17.3.17.10 Denmark Market Size and Forecast, by Device
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Application
      • 17.3.18.4 Finland Market Size and Forecast, by End User
      • 17.3.18.5 Finland Market Size and Forecast, by Technology
      • 17.3.18.6 Finland Market Size and Forecast, by Process
      • 17.3.18.7 Finland Market Size and Forecast, by Component
      • 17.3.18.8 Finland Market Size and Forecast, by Stage
      • 17.3.18.9 Finland Market Size and Forecast, by Services
      • 17.3.18.10 Finland Market Size and Forecast, by Device
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Application
      • 17.3.19.4 Russia Market Size and Forecast, by End User
      • 17.3.19.5 Russia Market Size and Forecast, by Technology
      • 17.3.19.6 Russia Market Size and Forecast, by Process
      • 17.3.19.7 Russia Market Size and Forecast, by Component
      • 17.3.19.8 Russia Market Size and Forecast, by Stage
      • 17.3.19.9 Russia Market Size and Forecast, by Services
      • 17.3.19.10 Russia Market Size and Forecast, by Device
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Component
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Device
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.5 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Component
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Device
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Application
      • 17.4.9.4 China Market Size and Forecast, by End User
      • 17.4.9.5 China Market Size and Forecast, by Technology
      • 17.4.9.6 China Market Size and Forecast, by Process
      • 17.4.9.7 China Market Size and Forecast, by Component
      • 17.4.9.8 China Market Size and Forecast, by Stage
      • 17.4.9.9 China Market Size and Forecast, by Services
      • 17.4.9.10 China Market Size and Forecast, by Device
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Application
      • 17.4.10.4 India Market Size and Forecast, by End User
      • 17.4.10.5 India Market Size and Forecast, by Technology
      • 17.4.10.6 India Market Size and Forecast, by Process
      • 17.4.10.7 India Market Size and Forecast, by Component
      • 17.4.10.8 India Market Size and Forecast, by Stage
      • 17.4.10.9 India Market Size and Forecast, by Services
      • 17.4.10.10 India Market Size and Forecast, by Device
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Application
      • 17.4.11.4 Japan Market Size and Forecast, by End User
      • 17.4.11.5 Japan Market Size and Forecast, by Technology
      • 17.4.11.6 Japan Market Size and Forecast, by Process
      • 17.4.11.7 Japan Market Size and Forecast, by Component
      • 17.4.11.8 Japan Market Size and Forecast, by Stage
      • 17.4.11.9 Japan Market Size and Forecast, by Services
      • 17.4.11.10 Japan Market Size and Forecast, by Device
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Application
      • 17.4.12.4 South Korea Market Size and Forecast, by End User
      • 17.4.12.5 South Korea Market Size and Forecast, by Technology
      • 17.4.12.6 South Korea Market Size and Forecast, by Process
      • 17.4.12.7 South Korea Market Size and Forecast, by Component
      • 17.4.12.8 South Korea Market Size and Forecast, by Stage
      • 17.4.12.9 South Korea Market Size and Forecast, by Services
      • 17.4.12.10 South Korea Market Size and Forecast, by Device
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Application
      • 17.4.13.4 Australia Market Size and Forecast, by End User
      • 17.4.13.5 Australia Market Size and Forecast, by Technology
      • 17.4.13.6 Australia Market Size and Forecast, by Process
      • 17.4.13.7 Australia Market Size and Forecast, by Component
      • 17.4.13.8 Australia Market Size and Forecast, by Stage
      • 17.4.13.9 Australia Market Size and Forecast, by Services
      • 17.4.13.10 Australia Market Size and Forecast, by Device
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Application
      • 17.4.14.4 Singapore Market Size and Forecast, by End User
      • 17.4.14.5 Singapore Market Size and Forecast, by Technology
      • 17.4.14.6 Singapore Market Size and Forecast, by Process
      • 17.4.14.7 Singapore Market Size and Forecast, by Component
      • 17.4.14.8 Singapore Market Size and Forecast, by Stage
      • 17.4.14.9 Singapore Market Size and Forecast, by Services
      • 17.4.14.10 Singapore Market Size and Forecast, by Device
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Application
      • 17.4.15.4 Indonesia Market Size and Forecast, by End User
      • 17.4.15.5 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.6 Indonesia Market Size and Forecast, by Process
      • 17.4.15.7 Indonesia Market Size and Forecast, by Component
      • 17.4.15.8 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.9 Indonesia Market Size and Forecast, by Services
      • 17.4.15.10 Indonesia Market Size and Forecast, by Device
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Application
      • 17.4.16.4 Taiwan Market Size and Forecast, by End User
      • 17.4.16.5 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.6 Taiwan Market Size and Forecast, by Process
      • 17.4.16.7 Taiwan Market Size and Forecast, by Component
      • 17.4.16.8 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.9 Taiwan Market Size and Forecast, by Services
      • 17.4.16.10 Taiwan Market Size and Forecast, by Device
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Application
      • 17.4.17.4 Malaysia Market Size and Forecast, by End User
      • 17.4.17.5 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.6 Malaysia Market Size and Forecast, by Process
      • 17.4.17.7 Malaysia Market Size and Forecast, by Component
      • 17.4.17.8 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.9 Malaysia Market Size and Forecast, by Services
      • 17.4.17.10 Malaysia Market Size and Forecast, by Device
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Application
    • 17.5.5 Latin America Market Size and Forecast, by End User
    • 17.5.6 Latin America Market Size and Forecast, by Technology
    • 17.5.7 Latin America Market Size and Forecast, by Process
    • 17.5.8 Latin America Market Size and Forecast, by Component
    • 17.5.9 Latin America Market Size and Forecast, by Stage
    • 17.5.10 Latin America Market Size and Forecast, by Services
    • 17.5.11 Latin America Market Size and Forecast, by Device
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Application
      • 17.5.9.4 Brazil Market Size and Forecast, by End User
      • 17.5.9.5 Brazil Market Size and Forecast, by Technology
      • 17.5.9.6 Brazil Market Size and Forecast, by Process
      • 17.5.9.7 Brazil Market Size and Forecast, by Component
      • 17.5.9.8 Brazil Market Size and Forecast, by Stage
      • 17.5.9.9 Brazil Market Size and Forecast, by Services
      • 17.5.9.10 Brazil Market Size and Forecast, by Device
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Application
      • 17.5.10.4 Mexico Market Size and Forecast, by End User
      • 17.5.10.5 Mexico Market Size and Forecast, by Technology
      • 17.5.10.6 Mexico Market Size and Forecast, by Process
      • 17.5.10.7 Mexico Market Size and Forecast, by Component
      • 17.5.10.8 Mexico Market Size and Forecast, by Stage
      • 17.5.10.9 Mexico Market Size and Forecast, by Services
      • 17.5.10.10 Mexico Market Size and Forecast, by Device
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Application
      • 17.5.11.4 Argentina Market Size and Forecast, by End User
      • 17.5.11.5 Argentina Market Size and Forecast, by Technology
      • 17.5.11.6 Argentina Market Size and Forecast, by Process
      • 17.5.11.7 Argentina Market Size and Forecast, by Component
      • 17.5.11.8 Argentina Market Size and Forecast, by Stage
      • 17.5.11.9 Argentina Market Size and Forecast, by Services
      • 17.5.11.10 Argentina Market Size and Forecast, by Device
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Component
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Device
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.5 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Component
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Device
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Component
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Device
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Application
      • 17.6.10.4 UAE Market Size and Forecast, by End User
      • 17.6.10.5 UAE Market Size and Forecast, by Technology
      • 17.6.10.6 UAE Market Size and Forecast, by Process
      • 17.6.10.7 UAE Market Size and Forecast, by Component
      • 17.6.10.8 UAE Market Size and Forecast, by Stage
      • 17.6.10.9 UAE Market Size and Forecast, by Services
      • 17.6.10.10 UAE Market Size and Forecast, by Device
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Application
      • 17.6.11.4 South Africa Market Size and Forecast, by End User
      • 17.6.11.5 South Africa Market Size and Forecast, by Technology
      • 17.6.11.6 South Africa Market Size and Forecast, by Process
      • 17.6.11.7 South Africa Market Size and Forecast, by Component
      • 17.6.11.8 South Africa Market Size and Forecast, by Stage
      • 17.6.11.9 South Africa Market Size and Forecast, by Services
      • 17.6.11.10 South Africa Market Size and Forecast, by Device
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Component
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Device
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Alvotech
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Coherus BioSciences
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Amgen
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Samsung Bioepis
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Celltrion
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Biocon
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Sandoz
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Mylan
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Fresenius Kabi
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Stada Arzneimittel
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Dr Reddy's Laboratories
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Lupin
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Hikma Pharmaceuticals
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Apotex
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Teva Pharmaceutical Industries
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Zydus Cadila
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Torrent Pharmaceuticals
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 Cadila Healthcare
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Alkem Laboratories
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 Gedeon Richter
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis